Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Youxinding capsule for depression (phase IIc)
ChiCTR2300070568Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of youxinding in major depressive episode (MDE) and major depressive disorder (MDD) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Montgomery-Åsberg Depression Rating Scale (MADRS). Started Mar 2021; status: completed.
02
Drugs
youxinding
03
Conditions
major depressive episode (MDE)major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2300070568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070568.